Koninklijke Philips (PHG) Research & Development (2009 - 2026)
Koninklijke Philips (PHG) recorded quarterly Research & Development of -$461.3 million in Q1 2026, up 76.69% quarter-over-quarter from -$2.0 billion in Q4 2025, and up 4.04% on a YoY basis from -$443.3 million in Q1 2025.
Koninklijke Philips (PHG) Research & Development (2009 - 2026) Analysis & Trends
Koninklijke Philips' Research & Development history runs 18 years deep, the most recent figure standing at -$461.3 million for Q1 2026.
- In Q1 2026, Research & Development rose 4.04% year-over-year to -$461.3 million; the TTM figure through Mar 2026 stood at -$3.9 billion (down 37.11% YoY), while the FY2025 annual figure was $2.0 billion, up 6.0% from the prior year.
- Research & Development was -$461.3 million for Q1 2026 at Koninklijke Philips, up from -$2.0 billion in the prior quarter.
- In the past five years, Research & Development ranged from a high of -$455.2 million in Q1 2024 to a low of -$2.1 billion in Q4 2022.
- Historically, Research & Development has averaged -$954.3 million across 5 years, with a median of -$566.7 million in 2023.
- The sharpest annual moves came in 2022 and 2024: Research & Development slumped 292.6% in 2022, then soared 75.2% in 2024.
- A 5-year view of Research & Development shows it stood at -$2.1 billion in 2022, then increased by 4.68% to -$2.0 billion in 2023, then jumped by 75.2% to -$504.4 million in 2024, then slumped by 292.34% to -$2.0 billion in 2025, then surged by 76.69% to -$461.3 million in 2026.
- The last three Research & Development figures came in at -$461.3 million (Q1 2026), -$2.0 billion (Q4 2025), and -$484.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 28.80 Mn |
| 10 | Zimmer Biomet Holdings | 17.18 Bn | 16.77 Bn | 1.51 Bn | 103.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -461.27 Mn |
| Dec 31, 2025 | -1.98 Bn |
| Sep 30, 2025 | -483.99 Mn |
| Jun 30, 2025 | -972.35 Mn |
| Mar 31, 2025 | -480.71 Mn |
| Dec 31, 2024 | -504.38 Mn |
| Sep 30, 2024 | -1.40 Bn |
| Jun 30, 2024 | -456.60 Mn |
| Mar 31, 2024 | -455.19 Mn |
| Dec 31, 2023 | -2.03 Bn |
| Sep 30, 2023 | -1.57 Bn |
| Jun 30, 2023 | -509.62 Mn |
| Mar 31, 2023 | -566.72 Mn |
| Dec 31, 2022 | -2.13 Bn |
| Sep 30, 2022 | -617.06 Mn |
| Jun 30, 2022 | -1.04 Bn |
| Mar 31, 2022 | -555.56 Mn |
| Dec 31, 2021 | -543.39 Mn |
| Sep 30, 2021 | -1.57 Bn |
| Jun 30, 2021 | -566.01 Mn |